A detailed history of Apollon Wealth Management, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 17,139 shares of TAK stock, worth $237,375. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,139
Previous 18,579 7.75%
Holding current value
$237,375
Previous $258,000 14.34%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$12.6 - $13.67 $18,144 - $19,684
-1,440 Reduced 7.75%
17,139 $221,000
Q1 2024

May 02, 2024

BUY
$13.89 - $15.04 $45,350 - $49,105
3,265 Added 21.32%
18,579 $258,000
Q4 2023

Feb 06, 2024

BUY
$13.36 - $15.43 $204,595 - $236,295
15,314 New
15,314 $218,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.